Short answer
PHIBRO ANIMAL HEALTH CORP (PAHC) filed an 8-K current report with the SEC on June 26, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Daniel Bendheim becomes CEO and President effective July 1, 2026, marking a leadership transition.
PHIBRO ANIMAL HEALTH CORP 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Daniel Bendheim becomes CEO and President effective July 1, 2026, marking a leadership transition
- Annual compensation: $850,000 base salary, 50% target bonus, and RSUs valued at approximately 50% of base salary
- Initial grant of 300,000 performance-based RSUs, vesting June 30, 2031 based on 90-day average stock price
- RSUs begin vesting at a $70 average share price and reach 100% vesting at $100 or above
- Change-in-control protections include accelerated vesting after delisting or qualifying termination within 12 months
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other PHIBRO ANIMAL HEALTH CORP 8-K filings
Get the next PAHC 8-K as it lands
Follow PAHC for push alerts, or ask the research agent what this filing means.